Zobrazeno 1 - 10
of 86
pro vyhledávání: '"Young Nam Lee"'
Autor:
Nagendra Kumar Kaushik, Hong Seon Kim, Young June Chae, Young Nam Lee, Gi-Chung Kwon, Eun Ha Choi, In Tae Kim
Publikováno v:
Molecules, Vol 17, Iss 10, Pp 11456-11468 (2012)
Di(3-thienyl)methanol (2) and di(3-thienyl)methane (3) have been synthesized and screened against the T98G (brain cancer) cell line. Treatment induced cell death (MTT and macro-colony assay), growth inhibition, cytogenetic damage (micronuclei formati
Externí odkaz:
https://doaj.org/article/0751c6780c084422a1231100d0695fbd
Autor:
Young Nam Lee, Paul D Bieniasz
Publikováno v:
PLoS Pathogens, Vol 3, Iss 1, p e10 (2007)
The human genome represents a fossil record of ancient retroviruses that once replicated in the ancestors of contemporary humans. Indeed, approximately 8% of human DNA is composed of sequences that are recognizably retroviral. Despite occasional repo
Externí odkaz:
https://doaj.org/article/f4111b92020c43578c906eb3bcab10d5
Autor:
Mark Bishton, Scott Marshall, Jatinder Harchowal, Gilles Salles, Camille Golfier, Alessandra Tucci, Alicia Rodriguez Fernández, Jose Javier Sanchez Blanco, Monica Bocchia, SooKyoung Kim, Young Nam Lee, Pier Luigi Zinzani
Publikováno v:
Hematological Oncology. 40:370-380
Rapid infusion (RI) of the rituximab biosimilar CT-P10 is currently only an approved treatment regimen for the treatment of rheumatoid arthritis. Although both CT-P10 and reference rituximab are known to be frequently administered using a RI regimen
Autor:
Young-Nam Lee
Publikováno v:
Taegu Science University Defense Security Institute. 4:89-97
Autor:
Hyoun-Ah, Kim, Eunyoung, Lee, Sun-Kyung, Lee, Yong-Beom, Park, Young Nam, Lee, Hee Jung, Kang, Kichul, Shin
Publikováno v:
Clinical and Experimental Rheumatology. 38:267-274
To evaluate the long-term drug retention, efficacy, and safety of the infliximab biosimilar CT-P13 in Korean patients with ankylosing spondylitis (AS) in clinical practice. The primary outcome was drug retention (i.e. time to treatment discontinuatio
Autor:
Young Nam Lee
Publikováno v:
The Journal of Korean Medieval History. 60:221-252
Autor:
Yeong Wook Song, Tae Hwan Kim, Shin-Seok Lee, Chang Hee Suh, Soo Kyoung Kim, Won Park, Dae Hyun Yoo, Young Nam Lee
Publikováno v:
Clinical drug investigation. 40(6)
The infliximab biosimilar CT-P13 has widely received regulatory approval in all indications of reference infliximab, including rheumatoid arthritis (RA) and ankylosing spondylitis (AS). This retrospective analysis investigated drug survival and long-
Autor:
Young Nam Lee, Hyoun-Ah Kim, Hee Jung Kang, Sun Kyung Lee, Yong Beom Park, Eunyoung Lee, Kichul Shin
Publikováno v:
Biodrugs
Objective The aim was to evaluate long-term drug retention, discontinuation, efficacy and safety of CT-P13 and reference infliximab in patients with rheumatoid arthritis (RA) enrolled in the Korean College of Rheumatology Biologics (KOBIO) registry.
Autor:
Young-nam Lee
Publikováno v:
Korean Police Studies Review. 16:197-222
Publikováno v:
Journal of Wind Engineering and Industrial Aerodynamics. 164:108-118
The bobsleigh bumper shape was optimized to reduce aerodynamic drag using three-dimensional Reynolds-averaged Navier–Stokes analysis and surrogate modeling. The k–ω shear stress transport turbulence model was used as turbulence closure. The nume